Table 1.
- Median cytokine levels evaluated among patients with different clinical COVID-19 and post-COVID-19 conditions.
| Clinical condition | IL-17Median (IQR) | IFN-γMedian (IQR) | TNF-αMedian (IQR) | IL-10Median (IQR) | IL-6Median (IQR) | IL-4Median (IQR) | IL-2Median (IQR) |
|---|---|---|---|---|---|---|---|
| COVID-19 | 15.45 (15.90) | 8.13 (3.15) | 6.20 (3.25) | 9.50 (3.21) | 12.22 (8.31) | 8.83 (15.90) | 6.88 (7.57) |
| Post-COVID-19 | 20.46 (15.59) | 8.54 (2.51) | 7.92 (4.65) | 9.64 (3.19) | 8.58 (4.47) | 8.73 (89.48) | 8.44 (2.72) |
| COVID-19 | |||||||
| Severe | 15.80 (16.24) | 8.42 (2.94) | 6.17 (3.66) | 9.46 (3.22) | 13.53 (11.35) | 8.04 (5.72) | 6.81 (2.46) |
| Mild/Moderate | 15.16 (15.28) | 7.32 (3.58) | 6.30 (3.19) | 9.50 (4.14) | 10.98 (5.01) | 9.31 (5.72) | 8.18 (2.60) |
| Post-COVID-19 | |||||||
| Severe | 20.41 (13.09) | 8.34 (3.76) | 6.85 (6.76) | 8.78 (2.95) | 8.22 (4.6) | 7.59 (7.61) | 7.60 (3.26) |
| Mild/Moderate | 20.50 (15.85) | 8.57 (2.26) | 8.23 (4.2) | 9.75 (3.24) | 8.67 (4.47) | 8.83 (7.89) | 8.60 (2.66) |
IIQ, interquartile range.